Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:HTGM

HTG Molecular Diagnostics (HTGM) Stock Price, News & Analysis

HTG Molecular Diagnostics logo

About HTG Molecular Diagnostics Stock (NASDAQ:HTGM)

Key Stats

Today's Range
N/A
50-Day Range
$5.01
$6.80
52-Week Range
N/A
Volume
773,040 shs
Average Volume
294,806 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HTGM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HTG Molecular Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HTGM Stock News Headlines

HTGMQ HTG Molecular Diagnostics, Inc.
HTG Molecular Diagnostics Inc HTGMQ
The Fed Just Got Kneecapped — Here’s What Happens Next
Donald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he’s kneecapped the Federal Reserve…tc pixel
HTG Molecular Diagnostics Inc (HTGMQ)
See More Headlines

HTGM Stock Analysis - Frequently Asked Questions

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) posted its quarterly earnings results on Wednesday, November, 10th. The medical research company reported ($0.60) EPS for the quarter, hitting analysts' consensus estimates of ($0.60). The medical research company earned $2.52 million during the quarter, compared to analysts' expectations of $2.90 million. HTG Molecular Diagnostics had a positive trailing twelve-month return on equity of 45.52% and a negative net margin of 324.25%.

HTG Molecular Diagnostics (HTGM) raised $50 million in an IPO on Wednesday, May 6th 2015. The company issued 3,600,000 shares at a price of $13.00-$15.00 per share. Leerink Partners served as the underwriter for the IPO and Canaccord Genuity and JMP Securities were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that HTG Molecular Diagnostics investors own include Sangamo Therapeutics (SGMO), Idera Pharmaceuticals (IDRA), NightHawk Biosciences (NHWK), Abeona Therapeutics (ABEO), Exelixis (EXEL), Bionano Genomics (BNGO) and Adamis Pharmaceuticals (ADMP).

Company Calendar

Last Earnings
11/10/2021
Today
9/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Analytical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:HTGM
CIK
1169987
Employees
84
Year Founded
1997

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$21.59 million
Net Margins
-324.25%
Pretax Margin
-324.05%
Return on Equity
45.52%
Return on Assets
8.93%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.40
Quick Ratio
1.30

Sales & Book Value

Annual Sales
$6.37 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.44 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
2,210,000
Free Float
2,156,000
Market Cap
N/A
Optionable
Optionable
Beta
0.99

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:HTGM) was last updated on 9/23/2025 by MarketBeat.com Staff
From Our Partners